Serum trypsinogen levels down in type 1 diabetes

Serum trypsinogen levels down in type 1 diabetes

(HealthDay)—Patients with type 1 diabetes have significantly lower serum trypsinogen levels than those without type 1 diabetes, according to a study published online Jan. 23 in Diabetes Care.

Xia Li, M.D., from the Second Xiangya Hospital in Changsha, China, and colleagues determined serum trypsinogen levels in 100 individuals with type 1 diabetes (72 new-onset, 28 established), 99 with type 1 diabetes-associated autoantibodies (AAb+) with varying levels of risk for developing diabetes, 87 AAb-negative (AAb−) controls, 91 AAb− relatives with type 1 diabetes, and 18 patients with type 2 diabetes.

The researchers found that in controls, trypsinogen levels increased significantly with age; while trypsinogen levels were significantly lower in patients with new-onset and established type 1 diabetes compared with AAb− controls, AAb− relatives, AAb+ subjects, and patients with type 2 diabetes. When considering age and in multivariate analysis, trypsinogen was reduced in multiple AAb+ subjects and patients with type 1 diabetes versus AAb− subjects (controls and relatives) and single-AAb+ subjects.

"These findings further support the interplay between pancreatic endocrine and exocrine dysfunction," the authors write. "Longitudinal studies are warranted to validate trypsinogen as a predictive biomarker of type 1 progression."

Explore further

Chronic hepatitis B prevalence higher in those with T2DM

More information: Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2017 HealthDay. All rights reserved.

Citation: Serum trypsinogen levels down in type 1 diabetes (2017, January 26) retrieved 23 June 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments